Inhibition of SOD1 trimerization is a novel drug target for ALS disease.
Saved in:
| Title: | Inhibition of SOD1 trimerization is a novel drug target for ALS disease. |
|---|---|
| Authors: | Woo, Tae-Gyun1 (AUTHOR), Han, Jin1 (AUTHOR), Kim, Yuju1 (AUTHOR), Hwang, Young jun2 (AUTHOR), Lee, Mua2 (AUTHOR), Kang, So-mi2 (AUTHOR), Park, Soyoung2 (AUTHOR), Ji, Yeongseon2 (AUTHOR), Chung, Yeon-Ho1 (AUTHOR), Baek, Songyoung1 (AUTHOR), Shin, Eunbyeol1 (AUTHOR), Minju-Kim1 (AUTHOR), Jang, Hyewon3 (AUTHOR), Shin, Yun-Jeong3 (AUTHOR), Kwon, Yonghoon3 (AUTHOR), Kim, Bae-Hoon1,2 (AUTHOR), Park, Bum-Joon1,2 (AUTHOR) bjpark1219@pusan.ac.kr |
| Source: | Translational Neurodegeneration. 5/12/2025, Vol. 14 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!